ACT pharmacists to lead the way in reducing incorrect, inappropriate or overuse of medicines

Friday 29 March 2019

 

The Pharmaceutical Society of Australia (PSA) encourages pharmacists and doctors to adopt DORA, the online clinical tool launched today by the ACT Government to help to reduce the harm that can be caused by people misusing pharmaceuticals.

 

DORA is an extension of the Drugs and Poisons Information System (DAPIS), which is the regulatory business system used by ACT Health to monitor prescribing and supply of controlled medicines.

 

In welcoming today’s announcement, PSA ACT Branch President Renae Beardmore outlined how DORA will assist doctors and pharmacists to make safer clinical decisions, particularly regarding controlled medicines.

 

“Every year, 250,000 Australians are admitted to hospital as a result of medicine-related problems, according to PSA’s Medicine Safety: Take Care report.

 

“This new clinical tool along with real time prescription reporting will support both doctors and pharmacists in addressing patient safety and the misuse of medicines such as opioids and stimulants through monitoring incorrect, inappropriate or overuse of these medicines.

 

“The ACT is leading the way in adopting a patient-focussed prescription monitoring system that will reduce medicine-related problems, address the issue of prescription medicine addiction and lead to better health outcomes for patients.”

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

SafeScript launched to save lives in Victoria

Monday 1 April 2019

 

The rollout of the SafeScript real-time prescription monitoring program in Victoria is a major step forward for medicine safety, according to the Pharmaceutical Society of Australia (PSA).

 

SafeScript rolls out statewide today and was launched by the Victorian Minister for Health the Hon Jenny Mikakos at previous PSA National President Joe Demarte’s Amcal Pharmacy in Carlton on Sunday.

 

PSA Victorian President Benjamin Marchant said PSA thanked the government for its commitment to protecting the public from medicine misuse with the SafeScript program.

 

“The Department of Health and Human Services has already made excellent progress with the introduction of SafeScript in the Western Victoria Primary Health Network and other areas since last October,” Mr Marchant said.

 

“Pharmacists and prescribers play a vital role in using SafeScript to improve patient safety by reviewing their patients’ prescription history for high-risk medicines.

 

“One of the key actions in PSA’s Pharmacists in 2023 report is to embrace digital transformation to improve the quality use of medicines; support the delivery of safe, effective, and efficient healthcare; and facilitate collaborative models of care.

 

“Technological improvement in pharmacist care through systems such as SafeScript allows us to make full use of pharmacists’ skills and improve the health of all Australians.

 

“Ultimately, SafeScript saves lives by empowering pharmacists and other healthcare professionals to work together to protect the community from risk of overdose.”

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

 

PSA welcomes re-election of New South Wales Government

Sunday 24 March 2019

 

The Pharmaceutical Society of Australia (PSA), in congratulating the return of the Berejiklian Government, asks them to commit to improving the health of the NSW community through supporting the vital role of pharmacists in the NSW healthcare system.

 

PSA NSW President Professor Peter Carroll said pharmacists’ unique expertise in the safe and effective use of medicines meant their role should be expanded to deliver care wherever medicines were used.

 

“The entire pharmacy workforce should be invested in to deliver safer, more effective and accessible care across NSW,” Prof Carroll said.

 

“PSA welcomes the re-election of the Liberal Party and congratulates them on the effective health policies they have already implemented in relation to vaccinations.

 

“PSA recently released our Pharmacists in 2023 report to highlight that pharmacists must be empowered to do more than the current healthcare system allows them to do.

 

“This is about the health of the public in NSW. We simply must be able to use more effectively the workforce that we have in pharmacists, across hospitals, in community pharmacy and in other areas.

 

“Giving consumers in NSW access to the influenza vaccine in community pharmacies has been a huge success.

 

“Pharmacist-administered flu vaccination has led to greater uptake amongst the community, increasing NSW’s overall herd immunity for these preventable diseases.”

 

A 2018 nationwide YouGov Galaxy poll showed that two-in-three Australians believe pharmacists should be able to administer common vaccines with greater convenience cited as a benefit.

 

“Pharmacists in NSW have also been protecting people 16 years and over from whooping cough and measles since January,” Prof Carroll said.

 

“PSA urges the Government to take full advantage of the pharmacist workforce by expanding pharmacist-administered vaccinations to make it easier for people to access adult pneumococcal and other vaccines.”

 

PSA also believes there are opportunities to provide the community with better access to specific prescription medicines for acute conditions by utilising the skills and expertise of trained pharmacists.

 

“Pharmacists can ease the burden on the health system and now is the time to commit to new reforms that allow them to provide better health outcomes for NSW,” Prof Carroll said.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

Outstanding WA pharmacists recognised

 

Wednesday 20 March 2019

 

Melinda Boss has received the WA Pharmacist of the Year Award at the annual Western Australian Pharmacist Awards night hosted by the Pharmaceutical Society of Australia (PSA).

 

PSA WA President Dr Fei Sim presented the award to Ms Boss at the University Club of Western Australia.

 

Lusi Sheehan was named WA Early Career Pharmacist of the Year and Emeritus Professor Dr Bruce Sunderland was presented with the WA Lifetime Achievement Award.

 

PSA National President Dr Chris Freeman delivered an engaging address on PSA’s work to enhance roles, recognition and remuneration for all pharmacists, as laid out in PSA’s Pharmacists in 2023 report.

 

Dr Sim congratulated Ms Boss on her important research and advocacy in the area of lactation.

 

“Melinda’s work demonstrates how a pharmacist can interact with the broader academic and medical community, raising the profile and influence of the pharmacy profession,” Dr Sim said.

 

Ms Sheehan received the Early Career Pharmacist Development Award for raising practice standards and providing a model of practice for her fellow Early Career Pharmacists.

 

“Lusi has extensive experience in community pharmacy and is a passionate advocate for the development of professional services,” Dr Sim said.

 

Dr Sim also congratulated Emeritus Professor Sunderland on his extensive experience and achievements in pharmaceutical education and research.

 

“Bruce has made significant contributions through a lifetime of commitment, leadership and dedication to the pharmacy profession.”

 

PSA also recognised new Life Members David Manners and Lawrence Spartalis on the evening, congratulating them for their 50-year membership with PSA.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

 

Flagship conference PSA19 showcases opportunities for pharmacists in 2023

Monday 18 March 2019

 

The flagship annual conference PSA19 will showcase how to enhance roles, recognition and remuneration for pharmacists as the custodians of medicine safety to improve healthcare for all Australians.

 

Early bird registrations are now open for the conference, hosted by the Pharmaceutical Society of Australia (PSA) from 26 to 28 July 2019 in Sydney.

 

PSA19 will tackle the theme of Pharmacists in 2023: unlocking your opportunities. The conference will build on PSA’s Pharmacists in 2023 report by highlighting ways to realise pharmacists’ full potential to improve access to healthcare and reduce variability in care.

 

International guest speakers including Young Australian of the Year 2009 Kurt Fearnley and patient safety advocate Melissa Sheldrick will headline PSA19.

 

Kurt Fearnley is a founding member of the National Disability Insurance Scheme’s Advisory Council, as well as a sailor, athlete, paralympian, fundraiser and inspirational speaker. He will deliver the 2019 Allan Russel Oration.

 

After losing her eight-year-old son in March 2016 following a series of dispensing errors, Melissa Sheldrick began advocating for mandatory error reporting across Canada. Her advocacy work is being heard all over the world.

 

PSA19’s diverse program offers innovative clinical, therapeutic and industry sessions for pharmacists in all practice settings, with a focus on medicine safety and expanded roles for pharmacists.

 

The popular Shark Tank session will return, giving a fresh round of candidates the chance to impress the judges and gain funding to make their pharmacy innovation a reality.

 

PSA is partnering with the Australasian Pharmaceutical Science Association (APSA) to enrich the research presented at the conference as the foundation for evidence-based pharmacist’s roles into 2023.

 

PSA19 will again be held in one of Sydney’s most exciting hotels and convention spaces, The Hyatt Regency Sydney in Darling Harbour.

 

Register now to secure your place at www.psa19.com

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

New online training to support people living with diabetes

Wednesday 6 March 2019

 

JOINT MEDIA RELEASE

 

A new online course to support pharmacists in caring for people living with diabetes has been launched today by the peak national body for all pharmacists, the Pharmaceutical Society of Australia (PSA) and Diabetes Qualified (DQ), the training arm of Diabetes NSW & ACT.

 

The Diabetes in Practice for Pharmacists course aims to help improve pharmacists’ health literacy to better support people living with diabetes to make informed choices about their health and thus improve health outcomes.

 

Diabetes in Practice for Pharmacists also supports several of the national priority actions in the recently released National Diabetes Implementation Strategy, contributing to the strategy’s goal of prioritising Australia’s response to diabetes and its complications and comorbidities, and reducing the impact of diabetes in the community.

 

PSA National President Dr Chris Freeman said the course focused on applying diabetes knowledge in everyday practice and supporting patients through better engagement, asking more meaningful questions and giving advice or referring on as needed.

 

“This new training program supports some of the key actions in PSA’s Pharmacists in 2023 by helping pharmacists in all practice settings have more supportive and meaningful conversations with their patients to prevent medicine misadventure and create better health outcomes,” Dr Freeman said.

 

“Diabetes is explained in simple terms using case studies and real life scenarios to provide examples of appropriate language to answer questions from a person living with diabetes about diabetes management and related products.”

 

Sturt Eastwood, CEO of Diabetes NSW & ACT said, “For many people living with diabetes their pharmacist is the health professional they see the most, so there is ample opportunity to have a conversation about diabetes care. We know that education leads to more effective self-care, which leads to reduced complications and better health outcomes.”

 

The course includes interactive modules and is relevant for pharmacists, intern pharmacists and pharmacy students with a special interest in diabetes. The introductory module is free for PSA members and the course provides pharmacists with the flexibility to work at their own pace.

 

To access individual modules or the full course, please visit the PSA website or DQ website.

 

The PSA and Australian Diabetes Educators Association (ADEA) co-developed Pharmacist Diabetes Educator career pathway also supports pharmacists providing services to people living with diabetes.

 

Media contacts:
PSA: Jarryd Luke, 0487 922 176
DQ: Danilia Walker, 02 9552 9904

Exceptional SA and NT pharmacists honoured

Workshops to help pharmacists make the most of My Health Record

Monday 4 March 2019

 

Pharmacists are invited to participate in a series of free interactive workshops designed to help them get the most out of My Health Record as a tool to support better patient care and health outcomes.

 

9 out of 10 Australians now have a My Health Record and approximately 15,460 healthcare providers are registered to use the system.

 

About 84% of community pharmacies are registered for My Health Record — and the Pharmaceutical Society of Australia and the Australian Digital Health Agency are committed to supporting pharmacists with training as they learn to use the system.

 

PSA National President Dr Chris Freeman said the workshops aligned with one of the key actions identified in PSA’s recent Pharmacists in 2023 report to make full use of pharmacists’ skills and improve the health of all Australians: Embrace digital transformation to improve the quality use of medicines; support the delivery of safe, effective, and efficient healthcare; and facilitate collaborative models of care.

 

“Pharmacists in 2023 states there is a strong need for technological improvement in pharmacist care,” Dr Freeman said.

 

“That’s why we identified technology as a key enabler that will support pharmacists in 2023 to be more responsible and accountable for medicines safety.

 

“These workshops will give pharmacists who are unfamiliar with the system the confidence to use My Health Record — and to communicate more effectively with other health professionals so they can deliver more coordinated care.

 

“At the end of the day, up-skilling pharmacists in the use of My Health Record will deliver better health outcomes and empower consumers through greater access to information.”

 

Pharmacists are invited to attend the Overcoming barriers to My Health Record implementation in pharmacy workshops between March and May 2019 to engage with Digital Health Leaders and explore how to implement and use the My Health Record effectively in their pharmacy.

 

Specialist workshops for accredited pharmacists to explore how to connect with My Health Record and embed it in their regular practice will also be provided.

 

Pharmacists can register online for the Overcoming barriers to My Health Record implementation in pharmacy workshops or the My Health Record for Accredited Pharmacists workshops, or call 1300 369 772 for more information.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

Leadership change at PSA

On Monday 25 February, Graham Catt decided to step down from his role as Chief Executive Officer of PSA. The Board has extended its best wishes to Graham for the future.

 

To ensure a seamless transition and certainty for our members and stakeholders, Dr Shane Jackson has been appointed as interim CEO and Belinda Wood appointed as Deputy CEO. Shane will step down from the PSA Board over this period.

 

The PSA Board thanks Shane for stepping into the role as interim CEO which will continue to see PSA focussed on ensuring that pharmacists are able to practise to full scope, and that they are appropriately remunerated and recognised for their key role in healthcare.

 

We look forward to Pharmacists in 2023 guiding the work of the PSA over the next few years and see that Shane and Belinda will be able to guide this work in the immediate future.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

PSA recognises leadership of retiring Pharmacy Guild Executive Director, David Quilty

Sun 24 February, 2019

 

The Pharmaceutical Society of Australia (PSA) today acknowledges the leadership of David Quilty as he steps down from his role as Executive Director for the Pharmacy Guild of Australia.

 

PSA National President Dr Chris Freeman said PSA had enjoyed a good working relationship with the Pharmacy Guild under David Quilty’s leadership.

 

“On behalf of the PSA Board, CEO and staff, I thank David for his leadership over the past six years,” Dr Freeman said.

 

“David has been a passionate and relentless advocate for community pharmacy and will be remembered for his role in negotiating the Sixth Community Pharmacy Agreement in 2015, and Pharmacy Compact in 2017. We wish David all the very best in his retirement.

 

“PSA looks forward to continuing to engage constructively with the incoming Executive Director on key issues of common interest to progress the roles, recognition and remuneration for pharmacists, so they can provide the best possible care to patients.”

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176